- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06456190
Testing STAR and TexSTAR: A Video and Text Messaging Intervention
Testing STAR and TextSTAR: A Video and Text Messaging Intervention for Recent Sexual Violence Survivors
Study Overview
Status
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Wisconsin
-
Madison, Wisconsin, United States, 53792
- University of Wisconsin
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Are 18 or older
- Can read and respond to questions in English
- Are receiving a SANE exam for sexual assault victimization within the previous week (7 days)
- Not currently or about to be hospitalized for severe injuries, suicidality, or psychosis
- Not currently or about to be incarcerated
Exclusion Criteria:
- Patients under age 18
- Those who cannot read and respond to questionnaires in English
- Those seeking care that does not include a SANE exam
- Those who cannot consent to receive SANE care.
- Those who are currently or about to be hospitalized for severe injuries, suicidality, or psychosis
- Those who are currently or about to be incarcerated (e.g., suspects, those who have experienced sexual assault within a prison setting and are returning to that setting, etc)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Factorial Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Video, Above Threshold, Text
Participants in this condition will receive the STAR intervention video and those who are above threshold on PTSD or opioid misuse at 1 week will be randomized to receive the textSTAR intervention.
|
a 12-15 minute video that includes psychoeducation about ptsd and substance misuse plus tips to not avoid safe but scary situations, cope with distress and urges to use, and engage with social support to aid recovery
a 3-week daily text program that includes supportive/empowering messages along with brief coping tips to not avoid safe but scary situations, cope with distress and urges to use, and engage with social support to aid recovery
|
|
Experimental: Video, Above Threshold, No Text
Participants in this condition will receive the STAR intervention video and those who are above threshold on PTSD or opioid misuse at 1 week will be randomized to not receive textSTAR.
|
a 12-15 minute video that includes psychoeducation about ptsd and substance misuse plus tips to not avoid safe but scary situations, cope with distress and urges to use, and engage with social support to aid recovery
|
|
Experimental: Video, Below Threshold
Participants in this condition will receive the STAR intervention video and will be below threshold on PTSD and opioid misuse at 1 week and will not be randomized to receive further intervention.
|
a 12-15 minute video that includes psychoeducation about ptsd and substance misuse plus tips to not avoid safe but scary situations, cope with distress and urges to use, and engage with social support to aid recovery
|
|
Experimental: No Video, Above Threshold, Text
Participants in this condition will not receive the STAR intervention video and those who are above threshold on PTSD or opioid misuse at 1 week will be randomized to receive the textSTAR intervention.
|
a 3-week daily text program that includes supportive/empowering messages along with brief coping tips to not avoid safe but scary situations, cope with distress and urges to use, and engage with social support to aid recovery
|
|
No Intervention: No Video, Above Threshold, No Text
Participants in this condition will not receive the STAR intervention video and those who are above threshold on PTSD or opioid misuse at 1 week will not be randomized to receive the textSTAR intervention.
|
|
|
No Intervention: No Video, Below Threshold
Participants in this condition will not receive the STAR intervention video and will be below threshold on PTSD and opioid misuse at 1 week and will not be randomized to receive further intervention.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Opioid Misuse
Time Frame: 1 week to 1 month
|
Assessed using Tobacco, Alcohol, Prescription Medication, and Other Substance (TAPS) Tool. The TAPS tool is a brief, two-part assessment of substance use and misuse. The TAPS-1 is a screener with 4 items assessing frequency of use of tobacco, alcohol, prescription medication, and illicit substances. Any response other than "never" on the TAPS-1 indicates a positive screen, which leads to administration of the TAPS-2. The TAPS-2 is a brief assessment including 3-4 yes/no questions for each class of substances assessing level of use, dependence, and concern from others. Cut-offs for problematic substance use and substance use disorder are based on scores on the TAPS-2. |
1 week to 1 month
|
|
Change in Posttraumatic Stress Disorder
Time Frame: 1 week to 1 month
|
Assessed using PTSD Checklist for DSM-5 (PCL-5).
The PCL-5 is a 20-item self-report measure that assesses the 20 DSM-5 symptoms of PTSD.
Scores range from 0-80, with scores of 31 or higher indicating probable PTSD.
|
1 week to 1 month
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Tobacco, Alcohol, and Other Drug Use
Time Frame: 1 month
|
Tobacco, Alcohol, Prescription Medication, and Other Substance (TAPS) Tool.
The TAPS-1 is a screener with 4 items assessing frequency of use of tobacco, alcohol, prescription medication, and illicit substances.
Any response other than "never" on the TAPS-1 indicates a positive screen, which leads to administration of the TAPS-2.
The TAPS-2 is a brief assessment including 3-4 yes/no questions for each class of substances assessing level of use, dependence, and concern from others.
Cut-offs for problematic substance use and substance use disorder are based on scores on the TAPS-2.
|
1 month
|
|
Opioid misuse severity
Time Frame: 1 month
|
Assessed using Current Opioid Misuse Measure (COMM), which is a brief patient self-assessment to monitor chronic pain patients on opioid therapy.
It is a 17-item questionnaire with a 0-4 point Likert scale.
Scores range from 0-68, with higher scores (above 9) indicating the participant may be exhibiting aberrant behaviors associated with misuse of opioid medications.
|
1 month
|
|
Depression level
Time Frame: 1 month
|
Assessed using the Patient Health Questionnaire-9 (PHQ-9) The PHQ-9 is an 9-item questionnaire where participants report how often in the past 2 weeks they were bothered by specific problems.
It is scored on a 4-point Likert scale where 0 = not at all to 3 = nearly every day.
The total possible range of scores is 0-27 where higher scores indicate more depressive symptoms.
|
1 month
|
|
Mindfulness skills usage
Time Frame: 1 week, 2 week, 3 week, 1 month
|
Assessed with 10 items from the Dialectical Behavior Therapy (DBT) skills subscale of the Ways of Coping Checklist, a 38 item self-report instrument that assesses DBT skills utilization in the past week on a scale from 0 = never to 3 = regularly.
The checklist has excellent psychometric properties and has been shown to discriminate patients who received skills training during treatment from those who did not.
Higher scores reflect greater skills utilization.
|
1 week, 2 week, 3 week, 1 month
|
|
Perceived control over recovery process
Time Frame: 1 month
|
Assessed with the 8-item Perceived Present Control subscale of the Perceived Control Over Stressful Events Scale.
The scale has excellent psychometric properties and higher scores (which reflect greater perceived control) have been associated with recovery following sexual violence.
|
1 month
|
|
Opioid craving
Time Frame: 1 week, 2 week, 3 week, 1 month
|
Assessed with the Opioid Craving Visual Analog Scale which ranges from 0 = No Craving At All to 100 = Strongest Craving Ever.
|
1 week, 2 week, 3 week, 1 month
|
|
Pain severity
Time Frame: 1 week, 2 week, 3 week, 1 month
|
Assessed with the Brief Pain Inventory (BPI), a 4-item self-report measure that asks participants to rate their worst pain in the last week, their least pain in the last week, their pain on average, and their pain right now on a scale from 0 = no pain at all to 10 = pain as bad as you can imagine.
An overall pain severity score is computed by taking the mean of the four items.
|
1 week, 2 week, 3 week, 1 month
|
|
Alcohol use severity
Time Frame: 1 month
|
Assessed with the 10-item Alcohol Use Disorders Identification Test (AUDIT), which quantifies consequences or problems associated with alcohol use.
Scores of 8 or higher on the AUDIT indicate substantial alcohol problems.
|
1 month
|
|
Drug use severity
Time Frame: 1 month
|
Assessed with the 10-item Drug Abuse Screening Test (DAST-10), which quantifies consequences or problems associated with drug use.
Scores of 6 or higher or the DAST-10 indicate substantial drug use problems.
|
1 month
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Kate Walsh, PhD, University of Wisconsin, Madison
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Trauma and Stressor Related Disorders
- Narcotic-Related Disorders
- Mental Disorders
- Substance-Related Disorders
- Chemically-Induced Disorders
- Stress Disorders, Traumatic
- Opioid-Related Disorders
- Stress Disorders, Post-Traumatic
- Technology, Industry, and Agriculture
- Technology
- Tape Recording
- Audiovisual Aids
- Educational Technology
- Television
- Videotape Recording
Other Study ID Numbers
- 2024-0299
- A487400 (Other Identifier: UW Madison)
- L&S/PSYCHOLOGY/PSYCHOLOGY (Other Identifier: UW Madison)
- 1R61DA059897-01 (U.S. NIH Grant/Contract)
- Protocol Version 8/28/2025 (Other Identifier: UW Madison)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Posttraumatic Stress Disorder
-
Sofie FolkeAarhus University Hospital; Copenhagen Trial Unit, Center for Clinical Intervention... and other collaboratorsNot yet recruiting
-
University Hospital, ToursCompletedPostTraumatic Stress DisorderFrance
-
ARQ National Psychotrauma CentreLeiden University Medical CenterEnrolling by invitationPosttraumatic Stress Disorder (PTSD)Netherlands
-
The University of Texas Health Science Center at...University of Pennsylvania; Brooke Army Medical Center; C.R.Darnall Army Medical... and other collaboratorsCompletedPosttraumatic Stress Disorder (PTSD)United States
-
Icahn School of Medicine at Mount SinaiCompletedPosttraumatic Stress Disorder (PTSD)United States
-
Berlin Center for the Treatment of Torture VictimsCompletedPosttraumatic Stress Disorder (PTSD)Germany
-
TEMPVA Research Group, Inc.C.R.Darnall Army Medical Center; VA Boston Healthcare System; Central Texas Veterans...UnknownPosttraumatic Stress Disorder, Combat-relatedUnited States
-
VA Office of Research and DevelopmentCompletedPosttraumatic Stress Disorder (PTSD)United States
-
Michael E. DeBakey VA Medical CenterSouth Central VA Mental Illness Research, Education & Clinical CenterCompletedPosttraumatic Stress Disorder (PTSD)United States
-
VA Office of Research and DevelopmentCompleted
Clinical Trials on Skills Training in Active Recovery (STAR) Video
-
University of Wisconsin, MadisonNational Institute on Drug Abuse (NIDA)Not yet recruitingSexual Violence | Opioid Misuse | Posttraumatic Stress Disorder (PTSD)United States
-
University Medical Center GroningenHanze University of Applied SciencesCompletedDepressionNetherlands
-
Yale UniversityTerminatedQuality of Life | Schizophrenia | Medication Adherence | Signs and Symptoms | Adjustment, PsychologicalUnited States
-
Universidad Nacional de Educación a DistanciaCompleted
-
Pro Consumer Safety - Public Health Behavior SolutionsUniversity of Southern CaliforniaCompletedMotor Vehicle InjuryUnited States
-
University of PittsburghU.S. Department of EducationCompleted
-
University of Sao PauloUnknownSchizophrenia and Disorders With Psychotic FeaturesBrazil
-
University of Texas at AustinTerminated
-
Foundation University IslamabadRecruitingNon-athletic Active Young AdultsPakistan
-
University of Maryland, BaltimoreNational Institute on Drug Abuse (NIDA)CompletedMood Disorders | Schizophrenia | Substance DependenceUnited States